A progressive group has proposed that Congress investigate Coinbase CEO Brian Armstrong and World Liberty Financial in 2027. The draft suggests questioning Armstrong about Coinbase's donation to a White House ballroom project and any benefits the company gained. It also calls for scrutiny of World Liberty Financial, focusing on President Trump's financial ties, eased crypto enforcement, and links to Binance. Although reviewed by Democratic staffers, the proposal is not an official congressional plan. Separately, Senator Richard Blumenthal has requested information from several crypto firms about donations to the ballroom project.
The proposed 2027 congressional scrutiny of Coinbase CEO Brian Armstrong and World Liberty Financial provides context for crypto market watchers. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Nov 14, 2026 00:41 WIB: out of 50 priced major cryptocurrencies, 20 rose and 29 fell today. Notable movers include EOS at Rp12.649 with an 8.13% increase and a typical hold time of 87 days, GRT at Rp330 up 7.11% but with 93% sell order activity, and BAT at Rp2.045 down 6.14% with 92% sell order activity and a typical hold time of 94 days.
Susan R. Burns, Ph.D., President of the University of Mount Saint Vincent, has been awarded the 2027 Courageous Leadership Award for her visionary and bold leadership. Since 2021, she has led the university through significant transformation, includi...
Solo, a company specializing in privacy-preserving human verification, has integrated its SDK into JellyJelly, a social video app co-founded by Venmo's co-founder. This integration ensures that every JellyJelly account belongs to a real, unique perso...
The U.S. market for AI-enabled ophthalmic diagnostic devices is projected to grow from $72.5 million in 2026 to $267.2 million by 2033, expanding at a 20.5% CAGR. Growth is driven by rising diabetes-related eye diseases, FDA clearances for autonomous...
The global medical display monitors market, valued at $2.8 billion in 2025, is projected to grow to $4.0 billion by 2033 with a CAGR of 4.6%. Growth is fueled by rising adoption of digital imaging systems, demand for accurate diagnostics, and healthc...
Oppenheimer downgraded Enovix from Outperform to Perform as the company expands production in South Korea and shifts focus to drone and smart-eyewear customers. Enovix reported a 38% revenue increase to $11 million in Q3 but saw its adjusted loss wid...
